{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:28:41Z","timestamp":1768523321612,"version":"3.49.0"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,2,2]],"date-time":"2013-02-02T00:00:00Z","timestamp":1359763200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Med."],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1007\/s11684-013-0243-9","type":"journal-article","created":{"date-parts":[[2013,2,2]],"date-time":"2013-02-02T15:42:23Z","timestamp":1359819743000},"page":"81-90","source":"Crossref","is-referenced-by-count":85,"title":["Impact of diabetes and its treatments on skeletal diseases"],"prefix":"10.1007","volume":"7","author":[{"given":"Wenbo","family":"Yan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,2,2]]},"reference":[{"issue":"9785","key":"243_CR1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(11)60679-X","volume":"378","author":"G Danaei","year":"2011","unstructured":"Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, Lin JK, Farzadfar F, Khang YH, Stevens GA, Rao M, Ali MK, Riley LM, Robinson CA, Ezzati M; Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Blood Glucose). National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 2011; 378 (9785): 31\u201340","journal-title":"Lancet"},{"issue":"33","key":"243_CR2","doi-asserted-by":"crossref","first-page":"25103","DOI":"10.1074\/jbc.R109.041087","volume":"285","author":"LJ Raggatt","year":"2010","unstructured":"Raggatt LJ, Partridge NC. Cellular and molecular mechanisms of bone remodeling. J Biol Chem 2010; 285(33): 25103\u201325108","journal-title":"J Biol Chem"},{"issue":"4","key":"243_CR3","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11154-010-9153-1","volume":"11","author":"EF Eriksen","year":"2010","unstructured":"Eriksen EF. Cellular mechanisms of bone remodeling. Rev Endocr Metab Disord 2010; 11(4): 219\u2013227","journal-title":"Rev Endocr Metab Disord"},{"issue":"1","key":"243_CR4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1146\/annurev-pathol-011110-130203","volume":"6","author":"X Feng","year":"2011","unstructured":"Feng X, McDonald JM. Disorders of bone remodeling. Annu Rev Pathol 2011; 6(1): 121\u2013145","journal-title":"Annu Rev Pathol"},{"issue":"2","key":"243_CR5","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/jbmr.320","volume":"26","author":"LF Bonewald","year":"2011","unstructured":"Bonewald LF. The amazing osteocyte. J Bone Miner Res 2011; 26 (2): 229\u2013238","journal-title":"J Bone Miner Res"},{"issue":"1","key":"243_CR6","first-page":"86","volume":"139","author":"AS Avrunin","year":"2011","unstructured":"Avrunin AS, Tikhilov RM. Osteocytic bone remodeling: history of the problem, morphological markers. Morfologiia 2011; 139(1): 86\u201394","journal-title":"Morfologiia"},{"issue":"9","key":"243_CR7","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1007\/s00198-010-1194-5","volume":"21","author":"GY Rochefort","year":"2010","unstructured":"Rochefort GY, Pallu S, Benhamou CL. Osteocyte: the unrecognized side of bone tissue. Osteoporos Int 2010; 21(9): 1457\u20131469","journal-title":"Osteoporos Int"},{"issue":"12","key":"243_CR8","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1007\/s00198-006-0172-4","volume":"17","author":"O Johnell","year":"2006","unstructured":"Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 2006; 17(12): 1726\u20131733","journal-title":"Osteoporos Int"},{"issue":"4","key":"243_CR9","first-page":"12","volume":"51","author":"NP Botushanov","year":"2009","unstructured":"Botushanov NP, Orbetzova MM. Bone mineral density and fracture risk in patients with type 1 and type 2 diabetes mellitus. Folia Med (Plovdiv) 2009; 51(4): 12\u201317","journal-title":"Folia Med (Plovdiv)"},{"issue":"1","key":"243_CR10","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00223-008-9195-5","volume":"84","author":"P Vestergaard","year":"2009","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L. Diabetes and its complications and their relationship with risk of fractures in type 1 and 2 diabetes. Calcif Tissue Int 2009; 84(1): 45\u201355","journal-title":"Calcif Tissue Int"},{"issue":"4","key":"243_CR11","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00198-005-0013-x","volume":"17","author":"LA Ahmed","year":"2006","unstructured":"Ahmed LA, Joakimsen RM, Berntsen GK, F\u00f8nneb\u00f8 V, Schirmer H. Diabetes mellitus and the risk of non-vertebral fractures: the Troms\u00f8 study. Osteoporos Int 2006; 17(4): 495\u2013500","journal-title":"Osteoporos Int"},{"issue":"5","key":"243_CR12","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/aje\/kwm106","volume":"166","author":"M Janghorbani","year":"2007","unstructured":"Janghorbani M, Van Dam RM, Willett WC, Hu FB. Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol 2007; 166(5): 495\u2013505","journal-title":"Am J Epidemiol"},{"issue":"7","key":"243_CR13","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.2337\/diacare.24.7.1192","volume":"24","author":"KK Nicodemus","year":"2001","unstructured":"Nicodemus KK, Folsom AR. Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women. Diabetes Care 2001; 24(7): 1192\u20131197","journal-title":"Diabetes Care"},{"issue":"9","key":"243_CR14","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1359\/jbmr.070510","volume":"22","author":"LC Hofbauer","year":"2007","unstructured":"Hofbauer LC, Brueck CC, Singh SK, Dobnig H. Osteoporosis in patients with diabetes mellitus. J Bone Miner Res 2007; 22(9): 1317\u20131328","journal-title":"J Bone Miner Res"},{"issue":"5","key":"243_CR15","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nrendo.2011.233","volume":"8","author":"C Hamann","year":"2012","unstructured":"Hamann C, Kirschner S, G\u00fcnther KP, Hofbauer LC. Bone, sweet bone-osteoporotic fractures in diabetes mellitus. Nat Rev Endocrinol 2012; 8(5): 297\u2013305","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"243_CR16","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00198-006-0253-4","volume":"18","author":"P Vestergaard","year":"2007","unstructured":"Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes\u2014a meta-analysis. Osteoporos Int 2007; 18(4): 427\u2013444","journal-title":"Osteoporos Int"},{"issue":"8","key":"243_CR17","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1007\/s11999-010-1702-0","volume":"469","author":"E Donnelly","year":"2011","unstructured":"Donnelly E. Methods for assessing bone quality: a review. Clin Orthop Relat Res 2011; 469(8): 2128\u20132138","journal-title":"Clin Orthop Relat Res"},{"issue":"2","key":"243_CR18","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00223-007-9082-5","volume":"82","author":"S Patel","year":"2008","unstructured":"Patel S, Hyer S, Tweed K, Kerry S, Allan K, Rodin A, Barron J. Risk factors for fractures and falls in older women with type 2 diabetes mellitus. Calcif Tissue Int 2008; 82(2): 87\u201391","journal-title":"Calcif Tissue Int"},{"issue":"10","key":"243_CR19","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.2337\/diacare.25.10.1749","volume":"25","author":"AV Schwartz","year":"2002","unstructured":"Schwartz AV, Hillier TA, Sellmeyer DE, Resnick HE, Gregg E, Ensrud KE, Schreiner PJ, Margolis KL, Cauley JA, Nevitt MC, Black DM, Cummings SR. Older women with diabetes have a higher risk of falls: a prospective study. Diabetes Care 2002; 25 (10): 1749\u20131754","journal-title":"Diabetes Care"},{"issue":"3","key":"243_CR20","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/ageing\/afr145","volume":"41","author":"E Pijpers","year":"2012","unstructured":"Pijpers E, Ferreira I, de Jongh RT, Deeg DJ, Lips P, Stehouwer CD, Nieuwenhuijzen Kruseman AC. Older individuals with diabetes have an increased risk of recurrent falls: analysis of potential mediating factors: the Longitudinal Ageing Study Amsterdam. Age Ageing 2012; 41(3): 358\u2013365","journal-title":"Age Ageing"},{"issue":"12","key":"243_CR21","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/gerona\/60.12.1539","volume":"60","author":"S Volpato","year":"2005","unstructured":"Volpato S, Leveille SG, Blaum C, Fried LP, Guralnik JM. Risk factors for falls in older disabled women with diabetes: the women\u2019s health and aging study. J Gerontol A Biol Sci Med Sci 2005; 60(12): 1539\u20131545","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"243_CR22","doi-asserted-by":"crossref","first-page":"539073","DOI":"10.1155\/2012\/539073","volume":"2012","author":"AK Azidah","year":"2012","unstructured":"Azidah AK, Hasniza H, Zunaina E. Prevalence of Falls and Its Associated Factors among Elderly Diabetes in a Tertiary Center, Malaysia. Curr Gerontol Geriatr Res 2012; 2012: 539073","journal-title":"Curr Gerontol Geriatr Res"},{"issue":"5","key":"243_CR23","doi-asserted-by":"crossref","first-page":"E735","DOI":"10.1152\/ajpendo.00159.2005","volume":"289","author":"KM Thrailkill","year":"2005","unstructured":"Thrailkill KM, Lumpkin CK Jr, Bunn RC, Kemp SF, Fowlkes JL. Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues. Am J Physiol Endocrinol Metab 2005; 289(5): E735\u2013E745","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3","key":"243_CR24","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s00774-009-0134-y","volume":"28","author":"I Barbagallo","year":"2010","unstructured":"Barbagallo I, Vanella A, Peterson SJ, Kim DH, Tibullo D, Giallongo C, Vanella L, Parrinello N, Palumbo GA, Di Raimondo F, Abraham NG, Asprinio D. Overexpression of heme oxygenase-1 increases human osteoblast stem cell differentiation. J Bone Miner Metab 2010; 28(3): 276\u2013288","journal-title":"J Bone Miner Metab"},{"issue":"6","key":"243_CR25","doi-asserted-by":"crossref","first-page":"e38752","DOI":"10.1371\/journal.pone.0038752","volume":"7","author":"E Keats","year":"2012","unstructured":"Keats E, Khan ZA. Unique responses of stem cell-derived vascular endothelial and mesenchymal cells to high levels of glucose. PLoS ONE 2012; 7(6): e38752","journal-title":"PLoS ONE"},{"key":"243_CR26","doi-asserted-by":"crossref","first-page":"378034","DOI":"10.1155\/2011\/378034","volume":"2011","author":"A Stolzing","year":"2011","unstructured":"Stolzing A, Colley H, Scutt A. Effect of age and diabetes on the response of mesenchymal progenitor cells to fibrin matrices. Int J Biomater 2011; 2011: 378034","journal-title":"Int J Biomater"},{"issue":"33","key":"243_CR27","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.3748\/wjg.15.4137","volume":"15","author":"S Kawahito","year":"2009","unstructured":"Kawahito S, Kitahata H, Oshita S. Problems associated with glucose toxicity: role of hyperglycemia-induced oxidative stress. World J Gastroenterol 2009; 15(33): 4137\u20134142","journal-title":"World J Gastroenterol"},{"issue":"2","key":"243_CR28","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.taap.2006.01.003","volume":"212","author":"AP Rolo","year":"2006","unstructured":"Rolo AP, Palmeira CM. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicol Appl Pharmacol 2006; 212(2): 167\u2013178","journal-title":"Toxicol Appl Pharmacol"},{"issue":"4","key":"243_CR29","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00418-004-0678-9","volume":"122","author":"GL King","year":"2004","unstructured":"King GL, Loeken MR. Hyperglycemia-induced oxidative stress in diabetic complications. Histochem Cell Biol 2004; 122(4): 333\u2013338","journal-title":"Histochem Cell Biol"},{"issue":"38","key":"243_CR30","doi-asserted-by":"crossref","first-page":"15087","DOI":"10.1073\/pnas.0703610104","volume":"104","author":"F Grassi","year":"2007","unstructured":"Grassi F, Tell G, Robbie-Ryan M, Gao Y, Terauchi M, Yang X, Romanello M, Jones DP, Weitzmann MN, Pacifici R. Oxidative stress causes bone loss in estrogen-deficient mice through enhanced bone marrow dendritic cell activation. Proc Natl Acad Sci USA 2007; 104(38): 15087\u201315092","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"243_CR31","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1210\/er.2009-0024","volume":"31","author":"SC Manolagas","year":"2010","unstructured":"Manolagas SC. From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis. Endocr Rev 2010; 31(3): 266\u2013300","journal-title":"Endocr Rev"},{"issue":"10","key":"243_CR32","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1007\/s00198-006-0155-5","volume":"17","author":"M Saito","year":"2006","unstructured":"Saito M, Fujii K, Mori Y, Marumo K. Role of collagen enzymatic and glycation induced cross-links as a determinant of bone quality in spontaneously diabetic WBN\/Kob rats. Osteoporos Int 2006; 17 (10): 1514\u20131523","journal-title":"Osteoporos Int"},{"issue":"1","key":"243_CR33","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1196\/annals.1433.044","volume":"1126","author":"R Sanguineti","year":"2008","unstructured":"Sanguineti R, Storace D, Monacelli F, Federici A, Odetti P. Pentosidine effects on human osteoblasts in vitro. Ann N Y Acad Sci 2008; 1126(1): 166\u2013172","journal-title":"Ann N Y Acad Sci"},{"issue":"7","key":"243_CR34","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1210\/jc.2008-2498","volume":"94","author":"AV Schwartz","year":"2009","unstructured":"Schwartz AV, Garnero P, Hillier TA, Sellmeyer DE, Strotmeyer ES, Feingold KR, Resnick HE, Tylavsky FA, Black DM, Cummings SR, Harris TB, Bauer DC; Health, Aging, and Body Composition Study. Pentosidine and increased fracture risk in older adults with type 2 diabetes. J Clin Endocrinol Metab 2009; 94 (7): 2380\u20132386","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"243_CR35","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/jbmr.321","volume":"26","author":"TL Clemens","year":"2011","unstructured":"Clemens TL, Karsenty G. The osteoblast: an insulin target cell controlling glucose homeostasis. J Bone Miner Res 2011; 26(4): 677\u2013680","journal-title":"J Bone Miner Res"},{"issue":"11","key":"243_CR36","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.1210\/jc.2010-1030","volume":"95","author":"G Karsenty","year":"2010","unstructured":"Karsenty G, Oury F. The central regulation of bone mass, the first link between bone remodeling and energy metabolism. J Clin Endocrinol Metab 2010; 95(11): 4795\u20134801","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"243_CR37","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1146\/annurev-physiol-020911-153233","volume":"74","author":"G Karsenty","year":"2012","unstructured":"Karsenty G, Oury F. Biology without walls: the novel endocrinology of bone. Annu Rev Physiol 2012; 74(1): 87\u2013105","journal-title":"Annu Rev Physiol"},{"issue":"10","key":"243_CR38","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.crvi.2011.07.007","volume":"334","author":"G Karsenty","year":"2011","unstructured":"Karsenty G. Bone endocrine regulation of energy metabolism and male reproduction. C R Biol 2011; 334(10): 720\u2013724","journal-title":"C R Biol"},{"issue":"5","key":"243_CR39","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.tem.2008.02.006","volume":"19","author":"NK Lee","year":"2008","unstructured":"Lee NK, Karsenty G. Reciprocal regulation of bone and energy metabolism. Trends Endocrinol Metab 2008; 19(5): 161\u2013166","journal-title":"Trends Endocrinol Metab"},{"issue":"3","key":"243_CR40","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.cell.2007.05.047","volume":"130","author":"NK Lee","year":"2007","unstructured":"Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, Dacquin R, Mee PJ, McKee MD, Jung DY, Zhang Z, Kim JK, Mauvais-Jarvis F, Ducy P, Karsenty G. Endocrine regulation of energy metabolism by the skeleton. Cell 2007; 130(3): 456\u2013469","journal-title":"Cell"},{"issue":"2","key":"243_CR41","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1530\/JOE-11-0452","volume":"213","author":"G Karsenty","year":"2012","unstructured":"Karsenty G. The mutual dependence between bone and gonads. J Endocrinol 2012; 213(2): 107\u2013114","journal-title":"J Endocrinol"},{"issue":"6","key":"243_CR42","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00774-012-0367-z","volume":"30","author":"A Movahed","year":"2012","unstructured":"Movahed A, Larijani B, Nabipour I, Kalantarhormozi M, Asadipooya K, Vahdat K, Akbarzadeh S, Farrokhnia M, Assadi M, Amirinejad R, Bargahi A, Sanjdideh Z. Reduced serum osteocalcin concentrations are associated with type 2 diabetes mellitus and the metabolic syndrome components in postmenopausal women: the crosstalk between bone and energy metabolism. J Bone Miner Metab 2012; 30(6): 683\u2013691","journal-title":"J Bone Miner Metab"},{"issue":"1","key":"243_CR43","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00198-010-1184-7","volume":"22","author":"I Kanazawa","year":"2011","unstructured":"Kanazawa I, Yamaguchi T, Yamauchi M, Yamamoto M, Kurioka S, Yano S, Sugimoto T. Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus. Osteoporos Int 2011; 22(1): 187\u2013194","journal-title":"Osteoporos Int"},{"issue":"1","key":"243_CR44","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1440-1681.2010.05463.x","volume":"38","author":"YQ Bao","year":"2011","unstructured":"Bao YQ, Zhou M, Zhou J, Lu W, Gao YC, Pan XP, Tang JL, Lu HJ, Jia WP. Relationship between serum osteocalcin and glycaemic variability in type 2 diabetes. Clin Exp Pharmacol Physiol 2011; 38(1): 50\u201354","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"3","key":"243_CR45","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s00223-009-9272-4","volume":"85","author":"I Kanazawa","year":"2009","unstructured":"Kanazawa I, Yamaguchi T, Yamamoto M, Yamauchi M, Yano S, Sugimoto T. Serum osteocalcin\/bone-specific alkaline phosphatase ratio is a predictor for the presence of vertebral fractures in men with type 2 diabetes. Calcif Tissue Int 2009; 85(3): 228\u2013234","journal-title":"Calcif Tissue Int"},{"issue":"6","key":"243_CR46","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/jama.285.6.785","volume":"285","author":"NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis,Therapy.","year":"2001","unstructured":"NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA 2001; 285(6): 785\u2013795","journal-title":"JAMA"},{"issue":"2","key":"243_CR47","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3109\/07435800.2010.496761","volume":"36","author":"AD Polymeris","year":"2011","unstructured":"Polymeris AD, Doumouchtsis KK, Giagourta I, Karga H. Effect of an oral glucose load on PTH, 250HD3, calcium, and phosphorus homeostasis in postmenopausal women. Endocr Res 2011; 36(2): 45\u201352","journal-title":"Endocr Res"},{"issue":"6","key":"243_CR48","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1053\/ajkd.2002.33400","volume":"39","author":"M Inaba","year":"2002","unstructured":"Inaba M, Nagasue K, Okuno S, Ueda M, Kumeda Y, Imanishi Y, Shoji T, Ishimura E, Ohta T, Nakatani T, Kim M, Nishizawa Y. Impaired secretion of parathyroid hormone, but not refractoriness of osteoblast, is a major mechanism of low bone turnover in hemodialyzed patients with diabetes mellitus. Am J Kidney Dis 2002; 39(6): 1261\u20131269","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"243_CR49","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s00223-004-0094-0","volume":"76","author":"M Inaba","year":"2005","unstructured":"Inaba M, Okuno S, Kumeda Y, Yamakawa T, Ishimura E, Nishizawa Y. Increased incidence of vertebral fracture in older female hemodialyzed patients with type 2 diabetes mellitus. Calcif Tissue Int 2005; 76(4): 256\u2013260","journal-title":"Calcif Tissue Int"},{"issue":"9","key":"243_CR50","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1210\/jc.2006-0460","volume":"91","author":"H Dobnig","year":"2006","unstructured":"Dobnig H, Piswanger-S\u00f6lkner JC, Roth M, Obermayer-Pietsch B, Tiran A, Strele A, Maier E, Maritschnegg P, Sieberer C, Fahrleitner-Pammer A. Type 2 diabetes mellitus in nursing home patients: effects on bone turnover, bone mass, and fracture risk. J Clin Endocrinol Metab 2006; 91(9): 3355\u20133363","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"243_CR51","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1046\/j.1523-1755.2000.00306.x","volume":"58","author":"ML Picton","year":"2000","unstructured":"Picton ML, Moore PR, Mawer EB, Houghton D, Freemont AJ, Hutchison AJ, Gokal R, Hoyland JA. Down-regulation of human osteoblast PTH\/PTHrP receptor mRNA in end-stage renal failure. Kidney Int 2000; 58(4): 1440\u20131449","journal-title":"Kidney Int"},{"issue":"5","key":"243_CR52","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1600-0501.2010.02047.x","volume":"22","author":"U Kuchler","year":"2011","unstructured":"Kuchler U, Spilka T, Baron K, Tangl S, Watzek G, Gruber R. Intermittent parathyroid hormone fails to stimulate osseointegration in diabetic rats. Clin Oral Implants Res 2011; 22(5): 518\u2013523","journal-title":"Clin Oral Implants Res"},{"issue":"3Suppl1","key":"243_CR53","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1097\/01.NAJ.0000412646.80054.21","volume":"112","author":"L Murphy","year":"2012","unstructured":"Murphy L, Helmick CG. The impact of osteoarthritis in the United States: a population-health perspective. Am J Nurs 2012; 112(3 Suppl 1): S13\u2013S19","journal-title":"Am J Nurs"},{"issue":"1038","key":"243_CR54","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1136\/pgmj.2010.146399rep","volume":"88","author":"F Berenbaum","year":"2012","unstructured":"Berenbaum F. Diabetes-induced osteoarthritis: from a new paradigm to a new phenotype. Postgrad Med J 2012; 88(1038): 240\u2013242","journal-title":"Postgrad Med J"},{"issue":"8","key":"243_CR55","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.2337\/dc12-0046","volume":"35","author":"YJ Cheng","year":"2012","unstructured":"Cheng YJ, Imperatore G, Caspersen CJ, Gregg EW, Albright AL, Helmick CG. Prevalence of diagnosed arthritis and arthritisattributable activity limitation among adults with and without diagnosed diabetes: United States, 2008\u20132010. Diabetes Care 2012; 35(8): 1686\u20131691","journal-title":"Diabetes Care"},{"issue":"2","key":"243_CR56","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.bone.2008.10.042","volume":"44","author":"RA Kayal","year":"2009","unstructured":"Kayal RA, Alblowi J, McKenzie E, Krothapalli N, Silkman L, Gerstenfeld L, Einhorn TA, Graves DT. Diabetes causes the accelerated loss of cartilage during fracture repair which is reversed by insulin treatment. Bone 2009; 44(2): 357\u2013363","journal-title":"Bone"},{"issue":"10","key":"243_CR57","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1002\/jcb.23196","volume":"112","author":"SC Rosa","year":"2011","unstructured":"Rosa SC, Rufino AT, Judas FM, Tenreiro CM, Lopes MC, Mendes AF. Role of glucose as a modulator of anabolic and catabolic gene expression in normal and osteoarthritic human chondrocytes. J Cell Biochem 2011; 112(10): 2813\u20132824","journal-title":"J Cell Biochem"},{"issue":"4","key":"243_CR58","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.maturitas.2012.05.013","volume":"72","author":"ML Davies-Tuck","year":"2012","unstructured":"Davies-Tuck ML, Wang Y, Wluka AE, Berry PA, Giles GG, English DR, Cicuttini FM. Increased fasting serum glucose concentration is associated with adverse knee structural changes in adults with no knee symptoms and diabetes. Maturitas 2012; 72 (4): 373\u2013378","journal-title":"Maturitas"},{"issue":"1","key":"243_CR59","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/1529-0131(200201)46:1<114::AID-ART10025>3.0.CO;2-P","volume":"46","author":"N Verzijl","year":"2002","unstructured":"Verzijl N, DeGroot J, Ben ZC, Brau-Benjamin O, Maroudas A, Bank RA, Mizrahi J, Schalkwijk CG, Thorpe SR, Baynes JW, Bijlsma JW, Lafeber FP, TeKoppele JM. Crosslinking by advanced glycation end products increases the stiffness of the collagen network in human articular cartilage: a possible mechanism through which age is a risk factor for osteoarthritis. Arthritis Rheum 2002; 46(1): 114\u2013123","journal-title":"Arthritis Rheum"},{"issue":"8","key":"243_CR60","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1053\/joca.2001.0469","volume":"9","author":"J DeGroot","year":"2001","unstructured":"DeGroot J, Verzijl N, Jacobs KM, Budde M, Bank RA, Bijlsma JW, TeKoppele JM, Lafeber FP. Accumulation of advanced glycation endproducts reduces chondrocyte-mediated extracellular matrix turnover in human articular cartilage. Osteoarthritis Cartilage 2001; 9(8): 720\u2013726","journal-title":"Osteoarthritis Cartilage"},{"issue":"4","key":"243_CR61","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/art.20170","volume":"50","author":"J DeGroot","year":"2004","unstructured":"DeGroot J, Verzijl N, Wenting-van Wijk MJ, Jacobs KM, Van El B, Van Roermund PM, Bank RA, Bijlsma JW, TeKoppele JM, Lafeber FP. Accumulation of advanced glycation end products as a molecular mechanism for aging as a risk factor in osteoarthritis. Arthritis Rheum 2004; 50(4): 1207\u20131215","journal-title":"Arthritis Rheum"},{"issue":"9","key":"243_CR62","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1002\/art.22042","volume":"54","author":"RR Yammani","year":"2006","unstructured":"Yammani RR, Carlson CS, Bresnick AR, Loeser RF. Increase in production of matrix metalloproteinase 13 by human articular chondrocytes due to stimulation with S100A4: Role of the receptor for advanced glycation end products. Arthritis Rheum 2006; 54(9): 2901\u20132911","journal-title":"Arthritis Rheum"},{"issue":"9","key":"243_CR63","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.febslet.2007.03.090","volume":"581","author":"SS Nah","year":"2007","unstructured":"Nah SS, Choi IY, Yoo B, Kim YG, Moon HB, Lee CK. Advanced glycation end products increases matrix metalloproteinase-1, -3, and -13, and TNF-\u03b1 in human osteoarthritic chondrocytes. FEBS Lett 2007; 581(9): 1928\u20131932","journal-title":"FEBS Lett"},{"issue":"4","key":"243_CR64","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/rheumatology\/kem376","volume":"47","author":"SS Nah","year":"2008","unstructured":"Nah SS, Choi IY, Lee CK, Oh JS, Kim YG, Moon HB, Yoo B. Effects of advanced glycation end products on the expression of COX-2, PGE2 and NO in human osteoarthritic chondrocytes. Rheumatology (Oxford) 2008; 47(4): 425\u2013431","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"243_CR65","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1093\/rheumatology\/keq380","volume":"50","author":"Z Rasheed","year":"2011","unstructured":"Rasheed Z, Akhtar N, Haqqi TM. Advanced glycation end products induce the expression of interleukin-6 and interleukin-8 by receptor for advanced glycation end product-mediated activation of mitogen-activated protein kinases and nuclear factor-kB in human osteoarthritis chondrocytes. Rheumatology (Oxford) 2011; 50(5): 838\u2013851","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"243_CR66","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1172\/JCI9017","volume":"105","author":"N Ogata","year":"2000","unstructured":"Ogata N, Chikazu D, Kubota N, Terauchi Y, Tobe K, Azuma Y, Ohta T, Kadowaki T, Nakamura K, Kawaguchi H. Insulin receptor substrate-1 in osteoblast is indispensable for maintaining bone turnover. J Clin Invest 2000; 105(7): 935\u2013943","journal-title":"J Clin Invest"},{"issue":"1","key":"243_CR67","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1083\/jcb.200204046","volume":"159","author":"T Akune","year":"2002","unstructured":"Akune T, Ogata N, Hoshi K, Kubota N, Terauchi Y, Tobe K, Takagi H, Azuma Y, Kadowaki T, Nakamura K, Kawaguchi H. Insulin receptor substrate-2 maintains predominance of anabolic function over catabolic function of osteoblasts. J Cell Biol 2002; 159(1): 147\u2013156","journal-title":"J Cell Biol"},{"issue":"10","key":"243_CR68","doi-asserted-by":"crossref","first-page":"e1058","DOI":"10.1371\/journal.pone.0001058","volume":"2","author":"N Kawamura","year":"2007","unstructured":"Kawamura N, Kugimiya F, Oshima Y, Ohba S, Ikeda T, Saito T, Shinoda Y, Kawasaki Y, Ogata N, Hoshi K, Akiyama T, Chen WS, Hay N, Tobe K, Kadowaki T, Azuma Y, Tanaka S, Nakamura K, Chung UI, Kawaguchi H. Akt1 in osteoblasts and osteoclasts controls bone remodeling. PLoS ONE 2007; 2(10): e1058","journal-title":"PLoS ONE"},{"issue":"4","key":"243_CR69","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1210\/jc.80.4.1194","volume":"80","author":"R Bouillon","year":"1995","unstructured":"Bouillon R, Bex M, Van Herck E, Laureys J, Dooms L, Lesaffre E, Ravussin E. Influence of age, sex, and insulin on osteoblast function: osteoblast dysfunction in diabetes mellitus. J Clin Endocrinol Metab 1995; 80(4): 1194\u20131202","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"243_CR70","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s001980070114","volume":"11","author":"MM Campos Pastor","year":"2000","unstructured":"Campos Pastor MM, L\u00f3pez-Ibarra PJ, Escobar-Jim\u00e9nez F, Serrano Pardo MD, Garc\u00eda-Cervig\u00f3n AG. Intensive insulin therapy and bone mineral density in type 1 diabetes mellitus: a prospective study. Osteoporos Int 2000; 11(5): 455\u2013459","journal-title":"Osteoporos Int"},{"issue":"18","key":"243_CR71","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1056\/NEJM199411033311803","volume":"331","author":"JJ Nolan","year":"1994","unstructured":"Nolan JJ, Ludvik B, Beerdsen P, Joyce M, Olefsky J. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N Engl J Med 1994; 331(18): 1188\u20131193","journal-title":"N Engl J Med"},{"issue":"7","key":"243_CR72","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1464-5491.1994.tb00333.x","volume":"11","author":"K Mimura","year":"1994","unstructured":"Mimura K, Umeda F, Hiramatsu S, Taniguchi S, Ono Y, Nakashima N, Kobayashi K, Masakado M, Sako Y, Nawata H. Effects of a new oral hypoglycaemic agent (CS-045) on metabolic abnormalities and insulin resistance in type 2 diabetes. Diabet Med 1994; 11(7): 685\u2013691","journal-title":"Diabet Med"},{"issue":"3","key":"243_CR73","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0168-8227(94)90112-0","volume":"24","author":"H Takino","year":"1994","unstructured":"Takino H, Okuno S, Uotani S, Yano M, Matsumoto K, Kawasaki E, Takao Y, Yamasaki H, Yamaguchi Y, Akazawa S, Nagataki S. Increased insulin responsiveness after CS-045 treatment in diabetes associated with Werner\u2019s syndrome. Diabetes Res Clin Pract 1994; 24(3): 167\u2013172","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"243_CR74","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0014-2999(94)90462-6","volume":"254","author":"K Murano","year":"1994","unstructured":"Murano K, Inoue Y, Emoto M, Kaku K, Kaneko T. CS-045, a new oral antidiabetic agent, stimulates fructose-2,6-bisphosphate production in rat hepatocytes. Eur J Pharmacol 1994; 254(3): 257\u2013262","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"243_CR75","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1210\/en.143.6.2376","volume":"143","author":"B Lecka-Czernik","year":"2002","unstructured":"Lecka-Czernik B, Moerman EJ, Grant DF, Lehmann JM, Manolagas SC, Jilka RL. Divergent effects of selective peroxisome proliferator-activated receptor-gamma 2 ligands on adipocyte versus osteoblast differentiation. Endocrinology 2002; 143(6): 2376\u20132384","journal-title":"Endocrinology"},{"issue":"1","key":"243_CR76","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.bone.2005.07.008","volume":"38","author":"OP Lazarenko","year":"2006","unstructured":"Lazarenko OP, Rzonca SO, Suva LJ, Lecka-Czernik B. Netoglitazone is a PPAR-\u03b3 ligand with selective effects on bone and fat. Bone 2006; 38(1): 74\u201384","journal-title":"Bone"},{"issue":"1","key":"243_CR77","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1210\/en.2003-0746","volume":"145","author":"SO Rzonca","year":"2004","unstructured":"Rzonca SO, Suva LJ, Gaddy D, Montague DC, Lecka-Czernik B. Bone is a target for the antidiabetic compound rosiglitazone. Endocrinology 2004; 145(1): 401\u2013406","journal-title":"Endocrinology"},{"issue":"9","key":"243_CR78","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1210\/jc.2005-2226","volume":"91","author":"AV Schwartz","year":"2006","unstructured":"Schwartz AV, Sellmeyer DE, Vittinghoff E, Palermo L, Lecka-Czernik B, Feingold KR, Strotmeyer ES, Resnick HE, Carbone L, Beamer BA, Park SW, Lane NE, Harris TB, Cummings SR. Thiazolidinedione use and bone loss in older diabetic adults. J Clin Endocrinol Metab 2006; 91(9): 3349\u20133354","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"243_CR79","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2337\/dc07-2270","volume":"31","author":"SE Kahn","year":"2008","unstructured":"Kahn SE, Zinman B, Lachin JM, Haffner SM, Herman WH, Holman RR, Kravitz BG, Yu D, Heise MA, Aftring RP, Viberti G; Diabetes Outcome Progression Trial (ADOPT) Study Group. Rosiglitazone-associated fractures in type 2 diabetes: an Analysis from A Diabetes Outcome Progression Trial (ADOPT). Diabetes Care 2008; 31(5): 845\u2013851","journal-title":"Diabetes Care"},{"issue":"2","key":"243_CR80","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1210\/jc.2009-1385","volume":"95","author":"ZA Habib","year":"2010","unstructured":"Habib ZA, Havstad SL, Wells K, Divine G, Pladevall M, Williams LK. Thiazolidinedione use and the longitudinal risk of fractures in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 2010; 95(2): 592\u2013600","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"243_CR81","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1210\/jc.2006-2646","volume":"92","author":"A Grey","year":"2007","unstructured":"Grey A, Bolland M, Gamble G, Wattie D, Horne A, Davidson J, Reid IR. The peroxisome proliferator-activated receptor-gamma agonist rosiglitazone decreases bone formation and bone mineral density in healthy postmenopausal women: a randomized, controlled trial. J Clin Endocrinol Metab 2007; 92(4): 1305\u20131310","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"243_CR82","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.2337\/dc06-2606","volume":"30","author":"S Yaturu","year":"2007","unstructured":"Yaturu S, Bryant B, Jain SK. Thiazolidinedione treatment decreases bone mineral density in type 2 diabetic men. Diabetes Care 2007; 30(6): 1574\u20131576","journal-title":"Diabetes Care"},{"issue":"6","key":"243_CR83","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1172\/JCI200419900","volume":"113","author":"T Akune","year":"2004","unstructured":"Akune T, Ohba S, Kamekura S, Yamaguchi M, Chung UI, Kubota N, Terauchi Y, Harada Y, Azuma Y, Nakamura K, Kadowaki T, Kawaguchi H. PPAR\u03b3 insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. J Clin Invest 2004; 113(6): 846\u2013855","journal-title":"J Clin Invest"},{"issue":"8","key":"243_CR84","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1002\/jbmr.366","volume":"26","author":"SW Cho","year":"2011","unstructured":"Cho SW, Yang JY, Her SJ, Choi HJ, Jung JY, Sun HJ, An JH, Cho HY, Kim SW, Park KS, Kim SY, Baek WY, Kim JE, Yim M, Shin CS. Osteoblast-targeted overexpression of PPAR\u03b3 inhibited bone mass gain in male mice and accelerated ovariectomy-induced bone loss in female mice. J Bone Miner Res 2011; 26(8): 1939\u20131952","journal-title":"J Bone Miner Res"},{"issue":"12","key":"243_CR85","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1038\/nm1672","volume":"13","author":"Y Wan","year":"2007","unstructured":"Wan Y, Chong LW, Evans RM. PPAR-gamma regulates osteoclastogenesis in mice. Nat Med 2007; 13(12): 1496\u20131503","journal-title":"Nat Med"},{"issue":"3","key":"243_CR86","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1210\/en.2004-0735","volume":"146","author":"AA Ali","year":"2005","unstructured":"Ali AA, Weinstein RS, Stewart SA, Parfitt AM, Manolagas SC, Jilka RL. Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation. Endocrinology 2005; 146(3): 1226\u20131235","journal-title":"Endocrinology"},{"issue":"3","key":"243_CR87","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/(SICI)1097-4644(19990901)74:3<357::AID-JCB5>3.0.CO;2-7","volume":"74","author":"B Lecka-Czernik","year":"1999","unstructured":"Lecka-Czernik B, Gubrij I, Moerman EJ, Kajkenova O, Lipschitz DA, Manolagas SC, Jilka RL. Inhibition of Osf2\/Cbfa1 expression and terminal osteoblast differentiation by PPAR\u03b32. J Cell Biochem 1999; 74(3): 357\u2013371","journal-title":"J Cell Biochem"},{"issue":"1","key":"243_CR88","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1210\/jc.2009-0572","volume":"95","author":"B Zinman","year":"2010","unstructured":"Zinman B, Haffner SM, Herman WH, Holman RR, Lachin JM, Kravitz BG, Paul G, Jones NP, Aftring RP, Viberti G, Kahn SE; ADOPT Study Group. Effect of rosiglitazone, metformin, and glyburide on bone biomarkers in patients with type 2 diabetes. J Clin Endocrinol Metab 2010; 95(1): 134\u2013142","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"243_CR89","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1677\/joe.1.05723","volume":"183","author":"MA Soroc\u00e9anu","year":"2004","unstructured":"Soroc\u00e9anu MA, Miao D, Bai XY, Su H, Goltzman D, Karaplis AC. Rosiglitazone impacts negatively on bone by promoting osteoblast\/ osteocyte apoptosis. J Endocrinol 2004; 183(1): 203\u2013216","journal-title":"J Endocrinol"},{"issue":"8","key":"243_CR90","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/j.1464-5491.2010.03048.x","volume":"27","author":"G Mabilleau","year":"2010","unstructured":"Mabilleau G, Mieczkowska A, Edmonds ME. Thiazolidinediones induce osteocyte apoptosis and increase sclerostin expression. Diabet Med 2010; 27(8): 925\u2013932","journal-title":"Diabet Med"},{"key":"243_CR91","first-page":"867180","volume":"2011","author":"W Wei","year":"2011","unstructured":"Wei W, Wan Y. Thiazolidinediones on PPAR\u03b3: the roles in bone remodeling. PPAR Res 2011; 2011: 867180","journal-title":"PPAR Res"},{"issue":"7","key":"243_CR92","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1007\/s00125-005-1786-3","volume":"48","author":"P Vestergaard","year":"2005","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L. Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk. Diabetologia 2005; 48(7): 1292\u20131299","journal-title":"Diabetologia"},{"issue":"12","key":"243_CR93","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1211\/jpp.60.12.0017","volume":"60","author":"Y Gao","year":"2008","unstructured":"Gao Y, Xue J, Li X, Jia Y, Hu J. Metformin regulates osteoblast and adipocyte differentiation of rat mesenchymal stem cells. J Pharm Pharmacol 2008; 60(12): 1695\u20131700","journal-title":"J Pharm Pharmacol"},{"issue":"2","key":"243_CR94","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.bone.2010.04.596","volume":"47","author":"M Shah","year":"2010","unstructured":"Shah M, Kola B, Bataveljic A, Arnett TR, Viollet B, Saxon L, Korbonits M, Chenu C. AMP-activated protein kinase (AMPK) activation regulates in vitro bone formation and bone mass. Bone 2010; 47(2): 309\u2013319","journal-title":"Bone"},{"issue":"1\u20133","key":"243_CR95","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ejphar.2010.02.051","volume":"635","author":"Y Gao","year":"2010","unstructured":"Gao Y, Li Y, Xue J, Jia Y, Hu J. Effect of the anti-diabetic drug metformin on bone mass in ovariectomized rats. Eur J Pharmacol 2010; 635(1\u20133): 231\u2013236","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"243_CR96","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1359\/jbmr.090732","volume":"25","author":"MS Molinuevo","year":"2010","unstructured":"Molinuevo MS, Schurman L, McCarthy AD, Cortizo AM, Tolosa MJ, Gangoiti MV, Arnol V, Sedlinsky C. Effect of metformin on bone marrow progenitor cell differentiation: in vivo and in vitro studies. J Bone Miner Res 2010; 25(2): 211\u2013221","journal-title":"J Bone Miner Res"},{"issue":"1\u20132","key":"243_CR97","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.mce.2011.04.003","volume":"339","author":"T Takatani","year":"2011","unstructured":"Takatani T, Minagawa M, Takatani R, Kinoshita K, Kohno Y. AMP-activated protein kinase attenuates Wnt\/\u03b2-catenin signaling in human osteoblastic Saos-2 cells. Mol Cell Endocrinol 2011; 339(1\u20132): 114\u2013119","journal-title":"Mol Cell Endocrinol"},{"issue":"4","key":"243_CR98","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.bone.2010.12.003","volume":"48","author":"WG Jang","year":"2011","unstructured":"Jang WG, Kim EJ, Bae IH, Lee KN, Kim YD, Kim DK, Kim SH, Lee CH, Franceschi RT, Choi HS, Koh JT. Metformin induces osteoblast differentiation via orphan nuclear receptor SHPmediated transactivation of Runx2. Bone 2011; 48(4): 885\u2013893","journal-title":"Bone"},{"issue":"5","key":"243_CR99","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jdiacomp.2009.05.002","volume":"24","author":"D Zhen","year":"2010","unstructured":"Zhen D, Chen Y, Tang X. Metformin reverses the deleterious effects of high glucose on osteoblast function. J Diabetes Complications 2010; 24(5): 334\u2013344","journal-title":"J Diabetes Complications"},{"issue":"6","key":"243_CR100","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1055\/s-2007-992786","volume":"116","author":"L Schurman","year":"2008","unstructured":"Schurman L, McCarthy AD, Sedlinsky C, Gangoiti MV, Arnol V, Bruzzone L, Cortizo AM. Metformin reverts deleterious effects of advanced glycation end-products (AGEs) on osteoblastic cells. Exp Clin Endocrinol Diabetes 2008; 116(6): 333\u2013340","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"10","key":"243_CR101","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1002\/jcb.23206","volume":"112","author":"QG Mai","year":"2011","unstructured":"Mai QG, Zhang ZM, Xu S, Lu M, Zhou RP, Zhao L, Jia CH, Wen ZH, Jin DD, Bai XC. Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats. J Cell Biochem 2011; 112(10): 2902\u20132909","journal-title":"J Cell Biochem"},{"issue":"7","key":"243_CR102","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.joen.2012.03.010","volume":"38","author":"L Liu","year":"2012","unstructured":"Liu L, Zhang C, Hu Y, Peng B. Protective effect of metformin on periapical lesions in rats by decreasing the ratio of receptor activator of nuclear factor kappa B ligand\/osteoprotegerin. J Endod 2012; 38(7): 943\u2013947","journal-title":"J Endod"},{"issue":"2","key":"243_CR103","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.diabres.2012.02.001","volume":"97","author":"WR Sukala","year":"2012","unstructured":"Sukala WR, Page R, Cheema BS. Exercise training in high-risk ethnic populations with type 2 diabetes: a systematic review of clinical trials. Diabetes Res Clin Pract 2012; 97(2): 206\u2013216","journal-title":"Diabetes Res Clin Pract"},{"issue":"7","key":"243_CR104","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/j.1463-1326.2012.01571.x","volume":"14","author":"AJ Dunkley","year":"2012","unstructured":"Dunkley AJ, Charles K, Gray LJ, Camosso-Stefinovic J, Davies MJ, Khunti K. Effectiveness of interventions for reducing diabetes and cardiovascular disease risk in people with metabolic syndrome: systematic review and mixed treatment comparison meta-analysis. Diabetes Obes Metab 2012; 14(7): 616\u2013625","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"243_CR105","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3132\/dvdr.2005.007","volume":"2","author":"JL Petersen","year":"2005","unstructured":"Petersen JL, McGuire DK. Impaired glucose tolerance and impaired fasting glucose\u2014a review of diagnosis, clinical implications and management. Diab Vasc Dis Res 2005; 2(1): 9\u201315","journal-title":"Diab Vasc Dis Res"},{"issue":"1","key":"243_CR106","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/1471-2474-13-177","volume":"13","author":"GA Kelley","year":"2012","unstructured":"Kelley GA, Kelley KS, Kohrt WM. Effects of ground and joint reaction force exercise on lumbar spine and femoral neck bone mineral density in postmenopausal women: a meta-analysis of randomized controlled trials. BMC Musculoskelet Disord 2012; 13 (1): 177","journal-title":"BMC Musculoskelet Disord"},{"issue":"6","key":"243_CR107","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s11357-011-9311-8","volume":"34","author":"EA Marques","year":"2012","unstructured":"Marques EA, Mota J, Carvalho J. Exercise effects on bone mineral density in older adults: a meta-analysis of randomized controlled trials. Age (Dordr) 2012; 34(6): 1493\u20131515","journal-title":"Age (Dordr)"}],"container-title":["Frontiers of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11684-013-0243-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11684-013-0243-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11684-013-0243-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T20:44:49Z","timestamp":1559421889000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11684-013-0243-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,2]]},"references-count":107,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["243"],"URL":"https:\/\/doi.org\/10.1007\/s11684-013-0243-9","relation":{},"ISSN":["2095-0217","2095-0225"],"issn-type":[{"value":"2095-0217","type":"print"},{"value":"2095-0225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,2]]}}}